Authors
Merve İnel, Elif Ozyilmaz
Published in
Nutrition reviews. Oct 06, 2026. Epub Oct 06, 2026.
Abstract
Flavonoids are widely consumed dietary polyphenols that have been extensively investigated for their antioxidant, anti-inflammatory, and anticancer properties. However, their role in oncology is more complex than is often assumed, as their biological effects may vary according to dose, bioavailability, metabolic transformation, tumour type, disease stage, and treatment context. This narrative review examines the dual and context-dependent nature of flavonoids in cancer biology, with emphasis on redox-dependent liabilities, genotoxicity, pharmacokinetic limitations, gut microbiota-mediated variability, and herb-drug interactions. The reviewed data indicate that flavonoids may exert protective, chemosensitizing, or regulatory effects under some conditions, while under others they may promote adaptive antioxidant responses, alter drug disposition, influence immune signaling, or produce adverse outcomes at supraphysiological exposure levels. Current evidence therefore does not support a uniformly beneficial interpretation of flavonoids in oncology. Rather, their significance lies in their biological duality and exposure-dependent behavior.
PMID:
42837266
Bibliographic data and abstract were imported from PubMed on 07 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 8
- Comments 0